mlsanityData to 14 Oct 2026

LIDDIA: Language-based Intelligent Drug Discovery Agent

arXiv 2502.13959 ↗First posted 19 Feb 2025cs.CLcited by 24

Not on the map. Why?

Abstract (arXiv)

Drug discovery is a long, expensive, and complex process, relying heavily on human medicinal chemists, who can spend years searching the vast space of potential therapies. Recent advances in artificial intelligence for chemistry have sought to expedite individual drug discovery tasks; however, there remains a critical need for an intelligent agent that can navigate the drug discovery process. Towards this end, we introduce LIDDIA, an autonomous agent capable of intelligently navigating the drug discovery process in silico. By leveraging the reasoning capabilities of large language models, LIDDIA serves as a low-cost and highly-adaptable tool for autonomous drug discovery. We comprehensively examine LIDDIA , demonstrating that (1) it can generate molecules meeting key pharmaceutical criteria on over 70% of 30 clinically relevant targets, (2) it intelligently balances exploration and exploitation in the chemical space, and (3) it identifies one promising novel candidate on AR/NR3C4, a critical target for both prostate and breast cancers. Code and dataset are available at https://github.com/ninglab/LIDDiA

Key facts. Cited by 24 papers in the map (data through 14 Oct 2026). Builds on 15 of its 57 references that are in the map. First posted on arXiv 19 Feb 2025.

Builds on

15 of 57 references.

References · 15

  1. 2022ReAct: Synergizing Reasoning and Acting in Language Modelscited by 8,695
  2. 2025DeepSeek-R1: Incentivizing Reasoning Capability in LLMs via Reinforcement Learningcited by 6,330
  3. 2024GPT-4o System Cardcited by 4,588
  4. 2023ChemCrow: Augmenting large-language models with chemistry toolscited by 631
  5. 2018Optimization of Molecules via Deep Reinforcement Learningcited by 200
  6. 2022Pocket2Mol: Efficient Molecular Sampling Based on 3D Protein Pocketscited by 183
  7. 20233D Equivariant Diffusion for Target-Aware Molecule Generation and Affinity Predictioncited by 177
  8. 2024Empowering Biomedical Discovery with AI Agentscited by 118
  9. 2024DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Designcited by 88
  10. 2020Retro*: Learning Retrosynthetic Planning with Neural Guided A* Searchcited by 76
  11. 2024OlympicArena: Benchmarking Multi-discipline Cognitive Reasoning for Superintelligent AIcited by 71
  12. 2024ProtAgents: Protein discovery via large language model multi-agent collaborations combining physics and machine learningcited by 64
3 more
  1. 2024CACTUS: Chemistry Agent Connecting Tool-Usage to Sciencecited by 33
  2. 2025Generating 3D Binding Molecules Using Shape-Conditioned Diffusion Models with Guidancecited by 10
  3. 2023Automated Bioinformatics Analysis via AutoBAcited by 6

Built on by

Cited by year (2026 to 14 Oct)

Citing papers per year: 2025: 11; 2026: 13.

24 papers.

Sort:

By area:

  1. 2025From LLM Reasoning to Autonomous AI Agents: A Comprehensive Reviewcited by 149
  2. 2025From AI for Science to Agentic Science: A Survey on Autonomous Scientific Discoverycited by 77
  3. 2025A Survey of LLM-Driven AI Agent Communication: Protocols, Security Risks, and Defense Countermeasurescited by 57
  4. 2026A Survey of Agentic Reasoning for Large Language Models: Towards Recursively Self-Improving and Collective Agentscited by 50
  5. 2025PiFlow: Principle-Aware Scientific Discovery with Multi-Agent Collaborationcited by 28
  6. 2026DeltaEvolve: Accelerating Scientific Discovery through Momentum-Driven Evolutioncited by 26
  7. 2025Autonomous Agents for Scientific Discovery: Orchestrating Scientists, Language, Code, and Physicscited by 11
  8. 2025Evolving Roles of LLMs in Scientific Innovation: Assistant, Collaborator, Scientist, and Evaluatorcited by 9
  9. 2025LARC: Towards Human-level Constrained Retrosynthesis Planning through an Agentic Frameworkcited by 9
  10. 2026MolClaw: An Autonomous Agent with Hierarchical Skills for Drug Molecule Evaluation, Screening, and Optimizationcited by 7
  11. 2026Mozi: Governed Autonomy for Drug Discovery LLM Agentscited by 5
  12. 2025Large Language Models for Controllable Multi-property Multi-objective Molecule Optimizationcited by 2
12 more
  1. 2025Breaking Bad Molecules: Are MLLMs Ready for Structure-Level Molecular Detoxification?cited by 2
  2. 2025Empowering Real-World: A Survey on the Technology, Practice, and Evaluation of LLM-driven Industry Agentscited by 2
  3. 2026Molecular Lead Optimization via Agentic Tool Planningcited by 2
  4. 2026MMORF: A Multi-agent Framework for Designing Multi-objective Retrosynthesis Planning Systemscited by 1
  5. 2026CAi Copilot: Reducing Operational Workload in Molecular Design through Intent-Driven Agentic Workflowscited by 1
  6. 2025FRAGMENTA: End-to-end Fragmentation-based Generative Model with Agentic Tuning for Drug Lead Optimizationcited by 0
  7. 2026Constraint-Aware Corrective Memory for Language-Based Drug Discovery Agentscited by 0
  8. 2026C-MORAL: Controllable Multi-Objective Molecular Optimization with Reinforcement Alignment for LLMscited by 0
  9. 2026BioResearcher: Scenario-Guided Multi-Agent for Translational Medicinecited by 0
  10. 2026Probe Before You Edit: Probing-Guided Molecular Optimization for LLM Agents in Structure-Based Drug Designcited by 0
  11. 2026CP-Agent: Context-Aware Multimodal Reasoning for Cellular Morphological Profiling under Chemical Perturbationscited by 0
  12. 2026A Precedent-Guided Co-Scientist for Side-Effect-Aware Drug Redesigncited by 0

Similar, not cited

Close in wording, no citation either way

  1. 2024DrugAgent: Automating AI-aided Drug Discovery Programming through LLM Multi-Agent Collaboration
  2. 2025Can AI Agents Design and Implement Drug Discovery Pipelines?
  3. 2025AI Agents in Drug Discovery
  4. 2025MADD: Multi-Agent Drug Discovery Orchestra
  5. 2026MADDIE: Multi-Agent Drug Discovery Engine
  6. 2025DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery
  7. 2025Large Language Model Agent for Modular Task Execution in Drug Discovery
  8. 2026Rhizome OS-1: Rhizome's Semi-Autonomous Operating System for Small Molecule Drug Discovery